ResearcherColumbia UniversityNo recent work listed
David Paul Horowitz
Matched on ORCID iD 0000-0002-4481-3770; OpenAlex author ID A5049525091. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 2, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 22
2011: 2 papers · 2012: none · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 2 papers · 2023: 1 paper
Papers 7
- Scorecards: Quantifying Dosimetric Plan Quality in Pancreatic Ductal Adenocarcinoma Stereotactic Body Radiation Therapy. Last author DOI 10.1016/j.adro.2023.101295↗
- Long-term follow-up experience with adjuvant therapy after irreversible electroporation of locally advanced pancreatic cancer. Co-author DOI 10.1002/jso.27085↗
- Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma. Co-author DOI 10.1080/2162402x.2022.2066767↗
- Radiotherapy for locally advanced pancreatic ductal adenocarcinoma. Last author DOI 10.1053/j.seminoncol.2021.02.005↗
- Radiation Therapy Deviations in Trial of Locally Advanced Pancreatic Cancer [corrected]. First author DOI 10.1001/jama.2016.9778↗
- Adjuvant chemoradiation therapy after pancreaticoduodenectomy in elderly patients with pancreatic adenocarcinoma. Co-author DOI 10.1016/j.ijrobp.2010.04.003↗
- Adjuvant Therapy of Pancreatic Cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011. First author PMID 21737892↗
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- John A. Chabot · 3 shared papers, 2011–2022 · strength 0.30
- Paper Long-term follow-up experience with adjuvant therapy after irreversible electroporation of locally advanced pancreatic … DOI 10.1002/jso.27085↗
- Paper Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma. DOI 10.1080/2162402x.2022.2066767↗
- Paper Adjuvant Therapy of Pancreatic Cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011. PMID 21737892↗
- Susan Elaine Bates · 2 shared papers, 2022 · strength 0.26
- Michael D. Kluger · 2 shared papers, 2022 · strength 0.26
- Beth Schrope · 2 shared papers, 2022 · strength 0.26
- Gulam Abbas Manji · 2 shared papers, 2022 · strength 0.26
- Elizabeth J. Buss · 1 shared paper, 2021 · strength 0.22
- Kareem N. Rayn · 1 shared paper, 2023 · strength 0.18
- Alexander S. Thomas · 1 shared paper, 2022 · strength 0.15
- Wooil Kwon · 1 shared paper, 2022 · strength 0.15
- A. Jani · 1 shared paper, 2016 · strength 0.12
- Yvonne M. Saenger · 1 shared paper, 2022 · strength 0.11
- Raúl Rabadán · 1 shared paper, 2022 · strength 0.11
- Thomas Enzler · 1 shared paper, 2022 · strength 0.11
- Robyn D. Gartrell · 1 shared paper, 2022 · strength 0.11
- Charu Sharma · 1 shared paper, 2011 · strength 0.04
- Muhammad Wasif Saif · 1 shared paper, 2011 · strength 0.04
- Charles Chia-chuen Hsu · 1 shared paper, 2011 · strength 0.03
- Joseph M. Herman · 1 shared paper, 2011 · strength 0.03
- Martin A. Makary · 1 shared paper, 2011 · strength 0.03
- Timothy Michael Pawlik · 1 shared paper, 2011 · strength 0.03
- Jordan Michael Winter · 1 shared paper, 2011 · strength 0.03
- Richard David Schulick · 1 shared paper, 2011 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.